Methaqualone was banned because it turned out to be far more addictive, more dangerous in overdose, and more prone to recreational abuse than anyone expected when it was introduced as a “safe” sleeping pill in the 1960s. By the early 1980s, the drug was killing people at alarming rates, and the U.S. government moved it to Schedule I in 1984, making it illegal to manufacture, prescribe, or possess.
What Methaqualone Was Prescribed For
Methaqualone was a synthetic sedative originally marketed for insomnia, anxiety, and muscle relaxation. It hit the market in the 1960s under brand names like Quaalude, Parest, Optimil, and Somnafac, typically in 200 mg or 400 mg capsules. Doctors at the time believed it was a safer alternative to barbiturates, which were notorious for causing fatal overdoses. That belief was wrong.
The drug works by amplifying the activity of GABA, the brain’s primary calming chemical. It binds to GABA receptors at a unique site and essentially forces the brain’s inhibitory system into overdrive, slowing nerve signaling throughout the central nervous system. This produces deep sedation, muscle relaxation, and a sense of euphoria that made it extremely appealing for recreational use.
The Euphoria Problem
A key reason methaqualone became so widely abused is that it produced more euphoria and less pure sedation than other drugs in its class. In a controlled comparison study, researchers found that methaqualone was “more euphoriant and less sedative” than benzodiazepines like lorazepam and alprazolam. In plain terms, it made people feel good without simply knocking them out. That’s a recipe for addiction.
Recreational users were taking anywhere from 75 mg to 2 grams per day, with the average hovering around 725 mg, well above the prescribed dose. Tolerance built quickly, meaning people needed more of the drug to get the same effect, which pushed them closer to dangerous territory with every dose increase.
Overdose Deaths and Violent Fatalities
The margin between a recreational dose and a lethal one was disturbingly narrow. Coma could occur after ingesting just 2.4 grams, and doses of 8 grams or more were fatal. Some deaths involved reported ingestions of 8 to 20 grams.
In the early 1970s, most methaqualone deaths were straightforward overdoses. But by the late 1970s, the pattern shifted in a disturbing direction. A JAMA survey of 246 methaqualone-related fatalities found that one third of victims died in car crashes. Sharp increases in traumatic suicides, non-vehicular accidents, and homicides linked to methaqualone use were documented after 1978. The drug didn’t just kill people who took too much. It impaired judgment and motor control so severely that users were dying in violent, chaotic ways.
Physical Dependence and Dangerous Withdrawal
Methaqualone caused physical dependence, not just psychological craving. The body adapted to its constant presence, and stopping abruptly could trigger a withdrawal syndrome that included seizures. Documented cases showed patients experiencing myoclonic jerks (sudden involuntary muscle spasms) and full tonic-clonic seizures, the kind involving loss of consciousness and violent whole-body convulsions. This made quitting the drug without medical supervision genuinely life-threatening, a trait it shared with alcohol and barbiturates but not with many other recreational drugs of that era.
How the Ban Happened
By the early 1980s, the evidence against methaqualone was overwhelming. Counterfeit tablets were flooding the black market, produced in underground labs with no quality control. So-called “stress clinics” were writing prescriptions with little or no medical justification, essentially functioning as legal drug dealers. The legitimate medical use of the drug had been completely overshadowed by its abuse.
In November 1983, the Lemmon Company, the sole remaining U.S. manufacturer of Quaalude, announced it was halting production. The company blamed “adverse legislation” and “unjustified negative publicity,” but the reality was that Congress was already preparing to ban the drug entirely. Lemmon’s own statement acknowledged that “widespread availability of illegally manufactured counterfeit methaqualone tablets and the illegal actions of so-called ‘stress clinics'” had made the situation untenable.
The following year, methaqualone was reclassified as a Schedule I controlled substance in the United States, placing it in the same category as heroin and LSD. Schedule I means the government considers it to have high abuse potential and no accepted medical use. By that point, benzodiazepines had largely replaced it in clinical practice, offering sedation and anxiety relief with a significantly wider margin of safety in overdose.
Why It Stayed Banned
There was never a compelling reason to bring methaqualone back. Benzodiazepines do the same job with a lower risk of fatal overdose, and newer sleep medications have further expanded the options available. Methaqualone’s unique pharmacological profile, binding to GABA receptors in a way that produces outsized euphoria, is precisely what made it medically problematic. A drug that feels that good is almost impossible to keep within the bounds of legitimate prescribing.
Internationally, methaqualone is controlled under the United Nations Convention on Psychotropic Substances, making it illegal or tightly restricted in virtually every country. Despite this, illicit use persists in parts of the world. In South Africa, methaqualone tablets sold under the street name Mandrax remain a significant drug problem. The drug is reported in all nine provinces, with particularly entrenched use in Western Cape Province. Most of this supply comes from clandestine manufacturing operations rather than diverted pharmaceutical stock, since no country still produces it legally for medical use.